骨质疏松与认知障碍关系的研究进展

doi:10.12114/j.issn.1007-9572.2021.01.314

中国全科医学 ›› 2022, Vol. 25 ›› Issue (11): 1406-1410.DOI: 10.12114/j.issn.1007-9572.2021.01.314

• 新进展 • 上一篇

骨质疏松与认知障碍关系的研究进展

任昀^1,², 陶立元³, 范东伟^4,^5,^6,^*

¹100191　北京市，北京大学第三医院妇产科
²100191　北京市，北京大学第三医院生殖医学中心
³100191　北京市，北京大学第三医院临床流行病学研究中心
⁴100191　北京市，北京大学第三医院骨科
⁵100191　北京市，脊柱疾病研究北京市重点实验室
⁶100191　北京市，北京大学　"骨与关节精准医学教育部工程中心"

收稿日期:2021-10-12 修回日期:2021-11-16 出版日期:2022-04-15 发布日期:2022-03-28
通讯作者: 范东伟
基金资助:
国家自然科学基金资助项目(30801156，41931291)

Research Progress on the Relationship between Osteoporosis and Cognitive Impairment

REN Yun1，2，TAO Liyuan3，FAN Dongwei4，5，6*

1.Department of Obstetrics and Gynecology，Peking University Third Hospital，Beijing 100191，China
2.Center for Reproductive Medicine，Peking University Third Hospital，Beijing 100191，China
3.Research Center of Clinical Epidemiology，Peking University Third Hospital，Beijing 100191，China
4.Department of Orthopaedics，Peking University Third Hospital，Beijing 100191，China
5.Beijing Key Laboratory of Spinal Disease Research，Beijing 100191，China
6.Engineering Research Center of Bone and Joint Precision Medicine，Ministry of Education，Beijing 100191，China
*Corresponding author：FAN Dongwei，Attending physician；E-mail：fdw@bjmu.edu.cn

Received:2021-10-12 Revised:2021-11-16 Published:2022-04-15 Online:2022-03-28

分享到

摘要/Abstract

摘要： 近年研究显示，在老年共病患者中，骨质疏松与认知障碍共病的发病率逐年上升，表现为跌倒发生率高，骨折风险增加，从而引起致残、致死率升高，严重危害共病患者的健康和生活质量，同时也给家庭和社会带来沉重的经济负担，成为目前社区慢性病管理中较为棘手的问题。本文对骨质疏松与认知障碍关系的进展进行综述。重点讨论骨质疏松与认知障碍的共病机制、共病临床危险因素及共病临床特征。发现骨质疏松与认知障碍关系密切，并严重危害老年人群健康。希望本文能为探索骨质疏松与认知障碍共病新的风险因素提供思路，为有效预防和管理骨质疏松与认知障碍共病提供帮助。

关键词: 骨质疏松, 认知障碍, 认知功能障碍, 骨质疏松性骨折, 慢性病共病, 骨-脑轴

Abstract:

In recent years, studies have shown that among elderly comorbidities, the incidence of comorbidity between osteoporosis and cognitive impairment is increasing year by year, which is manifested as a high incidence of falls and an increased risk of fractures, which leads to disability, increased mortality, and serious harm to health and quality of life of patients with comorbidities also bring a heavy economic burden to the family and society, which has become a more difficult problem in the management of chronic diseases in the community. This article reviews the progress of the relationship between osteoporosis and cognitive impairment. The focus is on the co-morbidity mechanism, clinical risk factors and clinical features of co-morbidity between osteoporosis and cognitive impairment. It is found that osteoporosis is closely related to cognitive impairment and seriously endangers the health of the elderly. It is hoped that this article can provide ideas for exploring new risk factors for comorbidity of osteoporosis and cognitive impairment, and provide help for the effective prevention and management of patients with comorbidity of osteoporosis and cognitive impairment.

Key words: Osteoporosis, Cognition Disorders, Cognitive Dysfunction, Osteoporotic fractures, Multiple chronic conditions, Bone-brain axis

中图分类号:

R681 R741

任昀,陶立元,范东伟. 骨质疏松与认知障碍关系的研究进展[J]. 中国全科医学, 2022, 25(11): 1406-1410. DOI: 10.12114/j.issn.1007-9572.2021.01.314.

REN Yun, TAO Liyuan, FAN Dongwei.

Research Progress on the Relationship between Osteoporosis and Cognitive Impairment [J]. Chinese General Practice, 2022, 25(11): 1406-1410.

参考文献 47

[1]	HILIGSMANN M，EVERS S M，BEN SEDRINE W，et al. A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis[J]. Pharmacoeconomics，2015，33（3）：205-224. DOI：10.1007/s40273-014-0231-1.
[2]	TURNER D A，KHIOE R F S，SHEPSTONE L，et al. The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK：economic evaluation of the SCOOP study[J]. J Bone Miner Res，2018，33（5）：845-851. DOI：10.1002/jbmr.3381.
[3]	WU J，QU Y，WANG K，et al. Healthcare resource utilization and direct medical costs for patients with osteoporotic fractures in China[J]. Value Heal Reg Issues，2019，18：106-111. DOI：10.1016/j.vhri.2018.11.008.
[4]	ZHANG C G，FENG J N，WANG S F，et al.Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study[J].PLoS Med，2020，17（8）: e1003180. DOI：10.1371/journal.pmed.1003180.
[5]	BRIGGS R，DYER A，NABEEL S，et al.Dementia in the acute hospital：the prevalence and clinical outcomes of acutely unwell patients with dementia[J].QJM，2017，110（1）：33-37. DOI：10.1093/qjmed/hcw114.
[6]	JIA L F，QUAN M N，FU Y，et al. Dementia in China：epidemiology，clinical management，and research advances[J]. Lancet Neurol，2020，19（1）：81-92. DOI：10.1016/S1474-4422(19)30290-X.
[7]	杨淞淳，吕筠，李立明.流行病学研究新进展[J]. 中华流行病学杂志，2020，41（1）：1-5. DOI：10.3760/cma.j.issn.0254-6450.2020.01.001.
[8]	SINGH I，HOOTON K，EDWARDS C，et al. Inpatient hip fractures：understanding and addressing the risk of this common injury[J]. Age Ageing，2020，49（3）：481-486. DOI：10.1093/ageing/afz179.
[9]	KERSCHAN-SCHINDL K. Prevention and rehabilitation of osteoporosis[J]. Wien Med Wochenschr，2016，166（1/2）：22-27. DOI：10.1007/s10354-015-0417-y.
[10]	WANG Y，TAO Y，HYMAN M E，et al. Osteoporosis in China[J]. Osteoporos Int，2009，20（10）：1651-1662. DOI：10.1007/s00198-009-0925-y.
[11]	NORDIN B E C，NEED A G，STEURER T，et al. Nutrition，osteoporosis，and aging[J]. Annals NY Acad Sci，1998，854（1 TOWARDS PROLO）: 336-351. DOI：10.1111/j.1749-6632.1998.tb09914.x.
[12]	DUCY P，AMLING M，TAKEDA S，et al. Leptin inhibits bone formation through a hypothalamic relay：a central control of bone mass[J]. Cell，2000，100（2）：197-207. DOI：10.1016/S0092-8674(00)81558-5.
[13]	ELEFTERIOU F. Impact of the autonomic nervous system on the skeleton[J]. Physiol Rev，2018，98（3）：1083-1112. DOI：10.1152/physrev.00014.2017.
[14]	YAVUZ KELES B，VURAL M，ÖNDER B，et al. Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women[J]. Turk J Med Sci，2020，50（4）：994-998. DOI：10.3906/sag-1909-187.
[15]	KELLY R R，MCDONALD L T，JENSEN N R，et al. Impacts of psychological stress on osteoporosis: clinical implications and treatment interactions[J]. Front Psychiatry，2019，10: 200. DOI：10.3389/fpsyt.2019.00200.
[16]	BERGER J M，SINGH P，KHRIMIAN L，et al. Mediation of the acute stress response by the skeleton[J]. Cell Metab，2019，30（5）：890-902.e8. DOI：10.1016/j.cmet.2019.08.012.
[17]	NOGUCHI T，EBINA K，HIRAO M，et al. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos，NFATc1，and NF-κB pathway[J]. Biochem Biophys Res Commun，2018，503（2）：644-650. DOI：10.1016/j.bbrc.2018.06.055.
[18]	DENGLER-CRISH C M，BALL H C，LIN L，et al. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease[J]. Neurobiol Aging，2018，67：148-158. DOI：10.1016/j.neurobiolaging.2018.03.021.
[19]	CUI S，XIONG F，HONG Y，et al. APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner[J]. J Bone Miner Res，2011，26（5）：1084-1098. DOI：10.1002/jbmr.299.
[20]	YANG M W，WANG T H，YAN P P，et al. Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice[J]. Phytomedicine，2011，18（2/3）：205-213. DOI：10.1016/j.phymed.2010.05.011.
[21]	XIA W F，JUNG J U，SHUN C，et al. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit，which are ameliorated by N-acetyl-L-cysteine[J]. J Bone Miner Res，2013，28（10）：2122-2135. DOI：10.1002/jbmr.1954.
[22]	DENGLER-CRISH C M，SMITH M A，WILSON G N. Early evidence of low bone density and decreased serotonergic synthesis in the dorsal raphe of a tauopathy model of Alzheimer's disease[J]. J Alzheimer's Dis，2016，55（4）：1605-1619. DOI：10.3233/jad-160658.
[23]	DENGLER-CRISH C M，BALL H C，LIN L，et al. Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease[J]. Neurobiol Aging，2018，67：148-158. DOI：10.1016/j.neurobiolaging.2018.03.021.
[24]	BEMILLER S M，MCCRAY T J，ALLAN K，et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy[J]. Mol Neurodegener，2017，12（1）: 1-12. DOI：10.1186/s13024-017-0216-6.
[25]	GUERREIRO R，WOJTAS A，BRAS J，et al. TREM2 variants in Alzheimer's disease[J]. N Engl J Med，2013，368（2）：117-127. DOI：10.1056/nejmoa1211851.
[26]	OBRI A，KHRIMIAN L，KARSENTY G，et al. Osteocalcin in the brain：from embryonic development to age-related decline in cognition[J]. Nat Rev Endocrinol，2018，14（3）：174-182. DOI：10.1038/nrendo.2017.181.
[27]	REINHOLT F P，HULTENBY K，OLDBERG A，et al. Osteopontin——a possible anchor of osteoclasts to bone[J]. PNAS，1990，87（12）：4473-4475. DOI：10.1073/pnas.87.12.4473.
[28]	CHO E H，CHO K H，LEE H A，et al. High serum osteopontin levels are associated with low bone mineral density in postmenopausal women[J]. J Korean Med Sci，2013，28（10）: 1496. DOI：10.3346/jkms.2013.28.10.1496.
[29]	FODOR D，BONDOR C，ALBU A，et al. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women[J]. J Investig Med，2013，61（1）：15-21. DOI：10.2310/jim.0b013e3182761264.
[30]	WANG K X，DENHARDT D T. Osteopontin: role in immune regulation and stress responses[J]. Cytokine Growth Factor Rev，2008，19（5/6）：333-345. DOI：10.1016/j.cytogfr.2008.08.001.
[31]	SIMONSEN A H，MCGUIRE J，HANSSON O，et al. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to alzheimer dementia in patients with mild cognitive impairment[J]. Arch Neurol，2007，64（3）: 366-370. DOI：10.1001/archneur.64.3.366.
[32]	COMI C，CARECCHIO M，CHIOCCHETTI A，et al. Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline[J]. J Alzheimer's Dis，2010，19（4）：1143-1148. DOI：10.3233/jad-2010-1309.
[33]	DOWNEY C L，YOUNG A，BURTON E F，et al. Dementia and osteoporosis in a geriatric population：is there a common link?[J]. World J Orthop，2017，8（5）：412-423. DOI：10.5312/wjo.v8.i5.412
[34]	ZHAO L H .2020 Alzheimer's disease facts and figures[J]. Alzheimers Dement，2020，16（3）：391-460. DOI：10.1002/alz.12068
[35]	SOHRABI H R，BATES K A，WEINBORN M，et al. Bone mineral density，adiposity，and cognitive functions[J]. Front Aging Neurosci，2015，7：16. DOI：10.3389/fnagi.2015.00016.
[36]	ZHOU R，ZHOU H D，RUI L，et al. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer's disease[J]. Curr Alzheimer Res，2014，11（7）：706-713. DOI：10.2174/1567205011666140812115818.
[37]	TARRANT S M，BALOGH Z J. The global burden of surgical management of osteoporotic fractures[J]. World J Surg，2020，44（4）：1009-1019. DOI：10.1007/s00268-019-05237-y.
[38]	CAULEY J A，CAWTHON P M，PETERS K E，et al. Risk factors for hip fracture in older men：the osteoporotic fractures in men study （MrOS）[J]. J Bone Miner Res，2016，31（10）：1810-1819. DOI：10.1002/jbmr.2836.
[39]	KANG H G，PARK H Y，RYU H U，et al. Bone mineral loss and cognitive impairment[J]. Medicine，2018，97（41）: e12755. DOI：10.1097/md.0000000000012755.
[40]	CATALANO A，SARDELLA A，BELLONE F，et al. Executive functions predict fracture risk in postmenopausal women assessed for osteoporosis[J]. Aging Clin Exp Res，2020，32（11）：2251-2257. DOI：10.1007/s40520-019-01426-w.
[41]	FOGG C，GRIFFITHS P，MEREDITH P，et al. Hospital outcomes of older people with cognitive impairment: an integrative review[J]. Int J Geriatr Psychiatry，2018，33（9）：1177-1197. DOI：10.1002/gps.4919.
[42]	HAO C T，CHUANG C S，Hung C H，et al. Fracture as an independent risk factor of dementia：a nationwide population-based cohort study[J]. Medicine （Baltimore），2014，93（26）：e188. DOI：10.1097/MD.0000000000000188.
[43]	LAVIKAINEN P，KOPONEN M，TAIPALE H，et al. Length of hospital stay for hip fracture and 30-day mortality in people with Alzheimer's disease: a cohort study in Finland[J]. Journals Gerontol: Ser A，2020，75（11）：2184-2192. DOI：10.1093/gerona/glaa199.
[44]	BERRY S D，ROTHBAUM R R，KIEL D P，et al. Association of clinical outcomes with surgical repair of hip fracture vs nonsurgical management in nursing home residents with advanced dementia[J]. JAMA Intern Med，2018，178（6）: 774-780. DOI：10.1001/jamainternmed.2018.0743.
[45]	BAE G，KIM E，KWON H Y，et al. Burden of osteoporotic fractures using disability-adjusted life years in South Korea[J]. Asia Pac J Public Heal，2020，32（2/3）：111-117. DOI：10.1177/1010539520916376.
[46]	CATALANO A，SARDELLA A，BELLONE F，et al. Executive functions predict fracture risk in postmenopausal women assessed for osteoporosis[J]. Aging Clin Exp Res，2020，32（11）: 2251-2257. DOI：10.1007/s40520-019-01426-w.
[47]	MURTHY L，DREYER P，SURIYAARACHCHI P，et al. Association between high levels of parathyroid hormone and frailty：the Nepean Osteoporosis and Frailty （NOF） study[J]. J Frailty Aging，20187（4）:253-257. DOI：10.14283/jfa.2018.22.

骨质疏松与认知障碍关系的研究进展

Research Progress on the Relationship between Osteoporosis and Cognitive Impairment

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 47

相关文章 15

编辑推荐

Metrics

留言

[1]	辛功恺, 丛欣, 袁磊, 程悦彤, 倪翠萍, 张巍巍, 張平平, 刘宇. 失智症老年人综合评估工具的研究进展[J]. 中国全科医学, 2023, 26(33): 4103-4109.
[2]	蹇秋枫, 徐荣华, 姚倩, 周媛媛. 中国老年脑卒中患者认知障碍患病率和影响因素的Meta分析[J]. 中国全科医学, 2023, 26(32): 4070-4079.
[3]	肖雨倩, 白艳杰, 王岩, 陈淑颖, 陈丽敏, 孙可心, 万俊. 线粒体转移在脑卒中后认知障碍中的研究进展[J]. 中国全科医学, 2023, 26(30): 3833-3840.
[4]	何莉, 张逸凡, 沈雪纯, 孙燕, 赵洋. 中国大陆地区居民慢性病共病的流行趋势：一项Meta分析[J]. 中国全科医学, 2023, 26(29): 3599-3607.
[5]	潘晔, 刘志辉, 胡倩倩, 王留义. 中国老年人慢性病多病共存模式的研究[J]. 中国全科医学, 2023, 26(29): 3608-3615.
[6]	周思静, 罗邦安, 曹慧, 张熙, 王东欣. ≥65岁居民老年痴呆流行病学特征及其与慢性病共病的相关性研究[J]. 中国全科医学, 2023, 26(29): 3616-3621.
[7]	何昱铮, 于吉庆, 郑建中, 佟岩. 宁夏回族自治区老年人健康促进行为与慢性病共病的关联分析[J]. 中国全科医学, 2023, 26(28): 3526-3532.
[8]	刘月, 刘琦, 董惠, 刘亚玲. 基于蒙特利尔认知评定量表双阈值定义的卒中后认知"恢复者"神经心理学变化研究[J]. 中国全科医学, 2023, 26(27): 3417-3422.
[9]	田萌, 宋玉磊, 张薛晴, 马云云, 梁晓, 石佳瑞, 殷海燕, 罗丹, 徐桂华, 柏亚妹. 主观认知下降老年人睡眠分型的潜在剖面分析及其影响因素研究[J]. 中国全科医学, 2023, 26(26): 3297-3302.
[10]	殷海燕, 宋玉磊, 徐桂华, 杜世正, 罗丹, 张薛晴, 柏亚妹. 脑力活动对老年人认知功能不同领域的影响研究[J]. 中国全科医学, 2023, 26(26): 3314-3319.
[11]	林洋, 王芳, 王寒, 武蓉, 王瑶, 徐子尧, 王旭, 王彦丁. 老年共病患者衰弱患病率的Meta分析[J]. 中国全科医学, 2023, 26(25): 3185-3193.
[12]	李梓盟, 王荣, 陈帅, 赵彩丽, 王晓聪, 温雅璐, 刘龙. 基于metaPRS与APOEε4优化轻度认知障碍遗传风险统计建模策略的应用研究[J]. 中国全科医学, 2023, 26(25): 3104-3111.
[13]	杨旭宏, 王明磊, 刘文潇, 马万龙, 赵建国, 黄雪莹, 王敏行, 丁向春, 王晓东. 基于静息态血氧水平依赖功能磁共振成像技术的度中心度评价轻型肝性脑病患者认知功能损害的研究[J]. 中国全科医学, 2023, 26(24): 3033-3041.
[14]	曾令烽, 杨伟毅, 梁桂洪, 肖萧, 罗明辉, 潘建科, 韩燕鸿, 黄和涛, 赵金龙, 徐南俊, 周光辉, 张献泉, 梁伟雄, 欧爱华, 刘军, 广东省中医药学会骨关节退变与损伤专业委员会. 骨质疏松高危人群中医症状评估专家问卷调查和结果研究[J]. 中国全科医学, 2023, 26(24): 2986-2991.
[15]	孟凡, 董敏洁, 郭瑾, 许松涛, 严薇, 顾俊, 陈忆蓉, 杨乘, 王军, 夏丽芳, 陈俊, 富灵杰. 社区老年人骨质疏松患病情况及全科防控策略[J]. 中国全科医学, 2023, 26(22): 2778-2784.